Introduction
Human adenoviruses (HAdVs) have been implicated in a wide range of human illnesses, including respiratory disease, gastroenteritis, pharyngitis, keratoconjunctivitis, meningoencephalitis, acute hemorrhagic cystitis, and hepatitis (Fields et al., 2013) . More than 60 types of HAdV, divided into eight species designated as A, B1, B2, C, D, E, F and G (http://hadvwg.gmu.edu), have been identified. Here we have analyzed the human adenovirus type 12 , which belongs to the highly oncogenic species A, to understand why this virus has a much lower virulence and causes slower infections in human tissue culture cells (Scheidtmann et al., 1975) compared to the non-oncogenic HAdV-2. Whereas the oncogenic potential of HAdV-12 in rodents is high and dependent on the viral oncogenes E1A and E1B, the reason(s) for the lower virulence remains to be explained.
Early recognition of HAdV infection by the innate immune system generates an antiviral response that is biased toward the type I interferon (IFN) pathway (Fejer et al., 2008; Nociari et al., 2007; Zhu et al., 2007) . The classical antiviral IFN response is initiated by cellular sensors of pathogen-associated molecular patterns that lead to activation of transcription factors of which interferon regulatory factor 3 (IRF3) is centrally important (Hiscott, 2007; Panne et al., 2007) . Activated IRF3 in combination with NF-κB and AP1 binds to the beta interferon (IFN-β) promoter, leading to expression of the IFN-β mRNA, as well as transcription of other IRF3-dependent genes (Nociari et al., 2009; Panne et al., 2007) . Activation of IRF3 requires phosphorylation, dimerization and subsequent nuclear localization of the factor. This cytoplasmic signaling cascade is initiated by cellular sensors that typically are virus-derived double-stranded RNA (dsRNA). HAdVs encode for one or two short RNA polymerase III products, called the virus associated RNAs (VA RNAs) (Mathews and Shenk, 1991; Punga et al., 2013) that are approximately 160 nucleotides long and display a highly double stranded nature. The VA RNAs induce IFN-β production, and the subsequent expression of IFN-stimulated genes, (ISGs) (Weber et al., 2006; Yamaguchi et al., 2010) is primarily through the RIG-I-mediated pathway, which recognizes the tri-phosphorylated status of the 5 0 -end of the VA RNAs (Minamitani et al., 2011) . Depending on the host cell, additional cellular factors contribute to IFN-β induction via viral DNA sensing cascades (Lam et al., 2014; Stein and Falck-Pedersen, 2012) .
Although the VA RNAs appear to be an important player in the early induction of IFN-β expression, a major function of VA RNAI of HAdV-5 is to enable the virus to evade cellular restriction of viral growth and maintain the translational capacity in the infected cell (Thimmappaya et al., 1982) . As a member of the family of ISGs, the serine/threonine protein kinase R (PKR) plays a key role in the establishment of the antiviral state by controlling the activity of the alpha subunit of eukaryotic initiation factor 2 (eIF2α) (Farrell et al., 1977; Samuel, 1993) . Activation of PKR occurs by dimerization and autophosphorylation of two PKR molecules binding to the same dsRNA. Activated PKR phosphorylates eIF2α, which results in a failure of ribosome assembly on the mRNA. In HAdV-5-infected cells a PKR monomer binds to the apical stem/central domain of VA RNAI (Launer-Felty and Cole, 2014; Mellits et al., 1990) . VA RNAI is produced in enormous quantities during HAdV-5 infection and leads to an antagonism of PKR activation (Mathews and Shenk, 1991; Punga et al., 2013) . Although the majority of HAdVs have two VA RNA species, HAdV-12 encodes only one VA RNA that is largely homologous to the HAdV-2/5 VA RNAI (reviewed in Ma and Mathews (1996) .
Our previous results revealed that HAdV-12 infection in human primary lung fibroblast, IMR-90 cells, is characterized by a slow progression of the lytic infection, a reduced cytopathic effect and a lower virus yield compared to the non-oncogenic HAdV-2 (Zhao et al., 2009) . By a cDNA microarray analysis we showed that several ISGs were up-regulated during the late phase of a HAdV-12 infection. We also observed similar effects in HAdV-12 infected HeLa cells (Dorn et al., 2005) . In this report we show that also in HAdV-12 infected A549 cells IFN-β induction was maintained throughout the infectious cycle. Both PKR and eIF2α were highly phosphorylated in HAdV-12 infected cells at times when late viral protein accumulation declined. In agreement with this observation, PKR knockdown experiments demonstrated that HAdV-12 was highly sensitive to PKR-mediated growth restriction. The inability of HAdV-12 to block the translational inhibition evoked by PKR correlated with an approximately 10,000-fold reduced accumulation of HAdV-12 VA RNA compared to HAdV-2 VA RNAI in A549 cells. Finally, we showed that overexpression of HAdV-2 VA RNAI in HAdV-12 infected cells rescued the translational capacity and increased the level of late structural protein accumulation by about 9-fold. Taken together, our results suggest that the poor growth and restricted virulence of HAdV-12 to a large extent are due to the low expression of HAdV-12 VA RNA and the subsequent inability to overcome PKR-mediated growth restriction.
Results and discussion
The poor growth of HAdV-12 correlates with premature cell death and restricted viral gene expression
The human A549 cell line is permissive for growth of many HAdVs. However, when compared to the highly efficient propagation of HAdV-2, HAdV-12 is characterized by slow progression of the virus life cycle and a low virus yield. A microscopic analysis of A549 cells infected with 10 FFU/cell of HAdV-2 showed a clear CPE that gradually increased with time and at 60 h p.i. most cells displayed a rounded shape and limited attachment to the plastic surface ( Fig. 1A ). Despite these significant changes in cell morphology, the integrity of HAdV-2 infected cells was intact as illustrated by the almost complete exclusion of trypan blue staining ( Fig. 1B) . In contrast, HAdV-12 infection failed to induce a typical CPE but instead caused changes resembling dying cells, i.e. smaller size and eventually complete disruption of the cellular integrity ( Fig. 1A) . Further, cell death induced by HAdV-12 was verified by staining of more than 60% of the cells with trypan blue at 60 h p.i. (Fig. 1B) .
To determine how the metabolic activity was affected by the observed changes in cell morphology, viral RNA and protein synthesis were analyzed at different time points of virus infection in A549 cells. RNA expression was quantitated by RT-PCR. In HAdV-2 infected cells, E1A mRNA expression was detectable at all time points and continued to accumulate throughout the infectious cycle, whereas E1A mRNA of HAdV-12 showed a delayed and significantly lower expression, with a maximal expression at 48 h p.i. ( Fig. 2A , and quantitated in Fig. 2B ). A similar pattern was observed for the late gene L3 where HAdV-12 L3 mRNAs started to decline after a peak at 36 h p.i. ( Fig. 2A , and quantitated in Fig. 2B ). Consistent with this observation, a Western-blot analysis of late structural protein accumulation showed that the HAdV-2 capsid proteins continued to accumulate throughout the infectious cycle whereas the steadystate level of structural proteins in HAdV-12 infected cells was significantly reduced and declined after a peak at 48 h p.i. (Fig. 2C , and quantitated in Fig. 2D ). Collectively, our results show that HAdV-12 infection of A459 cells is characterized by a delayed onset of viral gene expression and a premature cell death, together precluding the robust production of capsid proteins required for maximal progeny virion formation.
Although the E1A proteins of HAdV-2 and HAdV-12 are to a great extent equivalent and essential for activation of other viral genes, detailed analyses show significant differences in functional domains (Avvakumov et al., 2004) . This, for example, is manifested in the observation that the fraction of potential E2F target genes responding to HAdV-12 infection in HeLa cells is much smaller than what is seen during a HAdV-2 infection (Dorn et al., 2005; Zhao et al., 2007) . It is thus likely that both dynamics and kinetics in E1A-induced viral gene expression differ between the two virus types.
The lower virulence of HAdV-12 compared to HAdV-2 correlates with increased sensitivity to IFN
We have previously shown that HAdV-12 infection of primary lung epithelial cells (IMR-90) was severely delayed compared to infection by HAdV-2, and also induced an expression of a set of ISGs (Zhao et al., 2009) . Similarly, ISGs were also induced in HAdV-12 infected HeLa cells although here the consequences for virus production were less dramatic (Dorn et al., 2005) . To analyze whether type I IFN was involved in the restriction of HAdV-12 growth, we compared the growth kinetics of HAdV-2 and HAdV-12 in Vero cells that are defective in IFN-β expression as a result of a chromosomal deletion of the IFN-β gene (Park et al., 2006) . In the absence of IFN signaling, HAdV-2 and HAdV-12 demonstrated more similar growth rates with respect to production of steady-state levels of late viral proteins ( Fig. 3A ) and induction of CPE ( Fig. 3B ) compared to infection in A549 cells (Figs. 1A and 2C) . To analyze the impact of ISG expression on late viral protein synthesis we treated HAdV-2 and HAdV-12 infected Vero cells with IFN-α from 8, 18 or 24 h p.i. and onwards ( Fig. 3C ). Extracts were prepared at 60 h p.i. and late structural protein expression visualized by Western blotting. Addition of IFN-α at the early phase of infection (8 h p.i.) efficiently blocked HAdV-12 structural protein production but only had a negligible effect on HAdV-2 hexon production. When IFN-α treatment was initiated at 18 h p.i. HAdV-12 late protein expression was still efficiently suppressed, but when IFN-α was added after the late phase had commenced (24 h p.i.) essentially no inhibition of HAdV-12 late protein synthesis was observed ( Fig. 3C ). Taken together these results suggested that a major restriction factor for HAdV-12 growth in tissue culture cells is the failure of the virus to suppress the type I IFN response. Moreover, the findings also indicated that the sensitivity to the antiviral IFN activity is most pronounced during the early time points. A possible explanation might be that the abundant expression of late viral RNAs after onset of DNA replication efficiently competes for the cellular translation machinery.
We have previously shown that HAdV-12 infection of IMR-90 cells results in an induction of IFN-β expression (Zhao et al., 2009 ).
RT-PCR analysis of IFN-β mRNA levels in A549 infected cells showed that HAdV-2 in addition to HAdV-12 also induced IFN-β transcription during the early phase of infection ( Fig. 4A and quantitated in Fig. 4B ). However, in HAdV-2 infected cells, the induction of IFN-β mRNA accumulation was weak and reached a peak at 18-24 h p.i. followed by a decline (Fig. 4B ). In contrast, in HAdV-12 infected cells the IFN-β mRNA induction was 4-5 fold more robust and despite a decrease from 24 h p.i. and onwards, remained detectable throughout the entire infection (Fig. 4B ).
The reason for the different patterns of IFN induction by HAdV-2 and HAdV-12 is not clear. Activation of IFN-β occurs primarily through a cascade where sensing of different triggers leads to phosphorylation and nuclear translocation of IRF3. Double stranded (ds)RNA, produced by symmetrical transcription of the viral genome during the late phase of infection (Pettersson and Philipson, 1974) is one of the most efficient activators of IFN-β. The triphosphorylated 5 0 -end of VA RNAs triggers this cascade by RIG (Minamitani et al., 2011) . The viral genome itself can also act as a trigger through multiple DNA sensors recognizing the cytosolic viral DNA (Lam et al., 2014; Stein and Falck-Pedersen, 2012) . However, the temporal expression observed in our experiments does not directly agree with any of these being the responsible activator, unless the delayed and limited induction of IFN in HAdV-2 infected cells is the result of an active suppression of IFN-β. In support of the latter possibility is the observation that E1A of HAdV-2 and HAdV-12 differ in their capacity to bind p300 and as a consequence display a different capacity to interfere with IRF3-dependent activation of IFN-β transcription (Ackrill et al., 1991; Kalvakolanu et al., 1991) .
Sustained induction of IFN in HAdV-12 infected A549 cells correlates with increased phosphorylation of PKR and eIF-2α
The induction of IFN leads to activation of the JAK/STAT pathway, which in turn leads to activation of ISGs. One of these genes, PKR, has been shown to play a major role as an antiviral protein with a capacity to restrict HAdV growth (Punga et al., 2013; Samuel, 2001 ). Although modest, the observed induction of IFN-β expression ( Fig. 4) gave a transient increase of total PKR in HAdV-2 infected A549 cells, and a gradual increase in the total amount of PKR following an HAdV-12 infection (Fig. 5A ). More importantly, in HAdV-12 infected cells, phosphorylation of PKR appeared at 36 h p.i., whereas in HAdV-2 infected cells phosphorylated PKR was detectable only at the longest time after infection that was measured, 60 h p.i. Among the most important substrate of PKR, with respect to its antiviral activity, is eIF-2α (Samuel, 2001) . We therefore measured the accumulation of phosphorylated eIF-2α. As shown in Fig. 5B , activation of PKR in HAdV-12 infected cells simultaneously lead to a significant eIF-2α phosphorylation detectable already at 24 h p.i. In HAdV-2 infected cells, eIF-2α phosphorylation appeared both less and delayed (Fig. 5C ). Collectively, these results suggest that a failure of HAdV-12 to suppress PKR activation may be a major reason for the abortive replication of the virus observed in A549 cells.
To further test this hypothesis, we took advantage of the stable HeLa PKR kd cell line where PKR expression is knocked down to less than 2% of the control cell line HeLa PKR kd-con (Fig. 6A) by a shorthairpin RNA interference strategy (Zhang and Samuel, 2007) . To confirm the reduced PKR expression level, HeLa PKR kd and HeLa PKR kd-con were infected with HAdV-2 and PKR expression level was analyzed by Western-blot at 36, 48 and 60 h p.i. (Fig. 6A) . Depletion of PKR expression increased the steady-state level of viral structural proteins in HAdV-12 infected cells (Fig. 6B) , where as PKR depletion had no significant effect on viral late protein expression in HAdV-2 infected cells ( Fig. 6B) as shown by quantified protein amounts (Fig. 6C) . Taken together, these results are consistent with the hypothesis that activated PKR is primarily responsible for the suppression of HAdV-12 growth. However, VA RNAI is known to impair the function of dsRNA binding proteins and processes in addition to suppression of PKR activation and subsequent translation inhibition through eIF2 phosphorylation (Kitajewski et al., 1986; Mathews and Shenk, 1991) . For example, A-I editing activity of the dsRNA adenosine deaminase ADAR1 is antagonized by VA RNAI (Lei et al., 1998) and VA RNAI suppresses RNAi by binding and impairing Dicer (Andersson et al., 2005; Lu and Cullen, 2004) . The enhancement of HAdV-12 growth by knock down of PKR suggests that at least in the case of HAdV-12 the concentration of VA RNAI expressed in HeLa cells is sufficiently above the threshold required to impair the function of all targets other than PKR. The fact that knock down of PKR did not rescue the growth of HAdV-5 deleted for VA RNAI expression (Zhang and Samuel, 2007) suggests that one or more cellular proteins in addition to PKR are responsible for the restricted HAdV-5 mutant growth. Conceivably in the case of both HAdV-2 and HAdV-12 sufficiently high functional concentrations of VA RNAI are achieved to suppress functions other than PKR activation, whereas only with HAdV-2 and not HAdV-12 is the VA RNAI able to also suppress PKR.
The inability of HAdV-12 to evade the antiviral activity of PKR correlates with a severely reduced accumulation of HAdV-12 VA RNA compared to HAdV-2 VA RNAI Both HAdV-2 and HAdV-5 encode two homologous VA RNA genes, VA RNAI and VA RNAII. However, whereas VA RNAII is non-essential for lytic virus growth in tissue culture cells, VA RNAI is expressed in 10 8 copies/infected cell and is required to maintain an efficient translation during the late phase of infection (Punga et al., 2013) . VA RNAI sequesters PKR and prevents its activation and as a consequence ensures a high translational capacity during virus infection. HAdV-12 only encodes for one VA RNA species, which is homologous to HAdV-2/5 VA RNAI (Ma and Mathews, 1996) . It is conceivable that the failure of HAdV-12 to establish an efficient lytic replication in A549 cells could be due to insufficient levels of HAdV-12 VA RNA expression. Using an RT-qPCR approach we found that HAdV-2 VA RNAI accumulated to high levels in A549 cells reaching a maximum steady-state level at 36 h p.i. (Fig. 7) . Accumulation of HAdV-12 VA RNA also reached a maximum at about 36 h p.i. However, two major differences between HAdV-2 and HAdV-12 were apparent; first, whereas HAdV-2 VA RNA accumulated to a maximum of almost 10 8 molecules per cell, the maximum produced by HAdV-12 was approximately 10 4 molecules of VA RNA per cell (Fig. 7B) . Second, at the later time points after infection, VA RNA expression in HAdV-2 infected cells remained high, but in HAdV-12-infected cells the expression rapidly decreased.
HAdV-2 VA RNAs can rescue late viral protein synthesis in HAdV-12 infected cells
We have previously shown that complementation of adenovirus mutants lacking the VA RNAs can be efficiently achieved by transfection of VA RNA expressing plasmids and by measuring the production of late viral proteins by immunofluorescence (Larsson et al., 1986) .
A similar stratagem was therefore used to test whether the poor expression of viral protein in HAdV-12 infected cells could be rescued by ectopic overexpression of HAdV-2 VA RNA. Due to a poor transfection efficiency of A549 cells we performed the experiment in IMR-90 cells, where the transfection efficiency was over 80% (data not shown). IMR90 cells were transfected with plasmid pHindB, expressing the HAdV-2 VA RNAI and VA RNAII genes, or plasmid pAd12-VA, expressing the HAdV-12 VA RNA. Transfected cells were infected with HAdV-12 at 24 h post-transfection. At 48 h p.i. the cells were fixed and stained with a monoclonal antibody detecting the hexon protein. In IMR90 cells, the infection is slower than that in A549 cells and by 24 h p.i. the synthesis of late viral proteins has just started (Zhao et al., 2009) . As shown in Fig. 8 , pHindB cotransfection resulted in a 9-fold improvement of HAdV-12 hexon expression compared to mock-transfected IMR-90 cells. pAd12-VA cotransfection enhanced late protein synthesis less than 4-fold. In both cotransfection experiments, about 5-10 times more ectopically expressed VA RNA was obtained compared to levels expressed from the infected HAdV-12 genome (data not shown). Taken together, we conclude that the reduced translation of late proteins in HAdV-12 infected cells is due to insufficient amounts of VA RNA and that overexpression of either HAdV-2 VA RNA or HAdV-12 VA RNA can rescue the defect.
Conclusion
Herein we establish that an important contributing factor responsible for the slow and inefficient growth of HAdV-12 in A549 cells appears to be the failure of the HAdV-12 VA RNA to efficiently mount a suppressive effect on PKR activation. The failure to block PKR activation results in a prolonged phosphorylation of eIF2α, a low translational efficiency of late viral structural protein and a premature death of the infected cells. Although this has yet only been analyzed in infected tissue culture cells, the inability of HAdV12 to evade the INF response of the host may have implications for the virus to establish long-lasting or persistent infections in humans.
Materials and methods

Cell lines and virus
A549 (Human lung adenocarcinoma epithelial cells), IMR-90 (human lung fibroblasts), HeLa, and Vero cells (African green monkey kidney cell) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HeLa PKR kd and HeLa PKR kd-con (Zhang and Samuel, 2007) were maintained in DMEM containing 10% FBS and supplemented with 1 μg/ml puromycin (Sigma). HAdV-2 and HAdV-12 were amplified in HeLa cells and purified by cesium chloride density gradient centrifugation. Virus titers were measured as fluorescence forming units (FFU) (Philipson, 1961) using a panhexon antibody (MAB8052, Millipore).
Virus infection
Cells were mock-infected or infected in serum-free DMEM with indicated virus at a fixed multiplicity of 10 FFU/cell. After a 1 h adsorption period at 37 1C in humidified air with 5% CO 2 , the medium was replaced with DMEM supplemented with 2% FBS and the infected cells were further incubated at 37 1C with 5% CO 2 . The progression of infection was documented using a Leica DMIRB microscope at indicated time points post infection. At indicated times cells were harvested by trypsinization and the cell pellets were snap frozen for further RNA, DNA and/or protein extraction. Trypan blue exclusion was used to determine the number of viable cells. Briefly, at the indicated time point, trypan blue was added and the percentage of living cells was determined by counting both unstained and stained cells at 40 Â magnification and in three randomly chosen fields.
RNA preparation and RT-PCR
Collected cells were lysed in IsoB/NP40 (10 mM Tris pH 7.9, 0.15 M NaCl, and 1.5 mM MgCl 2 ) and total cytoplasmic RNA isolated by phenol extraction. The expression of E1A, L3 and actin mRNA was analyzed by reverse transcription followed by a PCR step (RT-PCR). First, single-stranded cDNA was generated from 2 mg cytoplasmic RNA by SuperScript TM II Reverse Transcriptase (Invitrogen) with Oligo (dT) 12-18 as primer, according to the manufacturer's instructions. Amplification of DNA was performed in a thermocycler with 50 ng of cDNA in a total volume of 25 ml. PCR products were analyzed by electrophoretic separation on a 1.2% agarose gel. The PCR primer sequences used were as follows: HAdV-2 E1A, 5 0 -GTGCCAGCGAGTAGA-3 0 and 5 0 -TGGTCCAAAA-GACTG-3 0 ; HAdV-12 E1A, 5 0 -ATGAGAACTGAAATGACTCCC-3 0 and 5 0 -CATTCACCGCCTGTTCATTAT-3 0 ; HAdV-2 L3, 5 0 -GCCTGTGGAC-TATTC-3 0 and 5 0 -CGGTAATAAGGTTCA-3 0 ; HAdV-12 L3, 5 0 -CAG-GATGCCTCGGAGTACCTGAG-3 0 and 5 0 -GGAGCCACGGTGGGGTT-3 0 ; Actin, 5 0 -CTGGGACGACATGGAGAAAA-3 0 and 5 0 -AAGGAAGGCTG-GAAGAGTGC-3 0 . The PCR reaction conditions were: 95 1C 5 min, (95 1C for 20 s, 58 1C for 20 s and 72 1C for 20 s) Â 30 cycles and 72 1C 10 min.
SYBR green qRT-PCR
For quantitative RT-PCR (qRT-PCR), total cellular RNA was isolated using the Trizol reagent (Invitrogen) as described by the manufacturer. Purified RNA was treated with DNaseI to remove residual genomic DNA. The concentration and purity of the RNA was quantified by NanoDrop spectrophotometry. A two-step qRT-PCR protocol was employed as follows: first, cDNA was synthesized from 2 μg of total RNA in a volume of 20 μl using SuperScript ™ II Reverse Transcriptase (Invitrogen); second, amplifications were carried out in a total volume of 20 μl by using iQ ™ SYBR Green Supermix (Bio-Rad) in a Miniopticon Real-Time PCR System (Bio.Rad, CFB-3120). Cycles conditions were 95 1C 10 min (95 1C for 15 s, 58 1C for 20 s, and 72 1C for 20 s) times 40. All samples were analyzed in technical triplicate. Nontemplate and non-RT controls were run with every assay. The absolute abundance of each mRNA was calculated using a standard curve (Giulietti et al., 2001) .
Protein preparation and Western blotting
The collected cell pellets were lysed on ice for 30 min in 50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1% deoxycholate, 1% Tween-20 and a protease inhibitor cocktail (Roche). Lysates were centrifuged at 12,000 rpm for 10 min at 4 1C, and the supernatants were collected. 15 μg of protein lysate was mixed with 2 Â Laemmli sample buffer (62.5 mM Tris-HCl pH 6.8, 25% glycerol, 0.01% BFB and 2% SDS), boiled for 5 min and separated on a 10% SDS-PAGE. Following blotting onto an Immobilon-FL Transfer Membrane (Millipore), the membranes were probed with the polyclonal anti-Prage antibody directed against purified HAdV-2 virions (Prage et al., 1970) , β-actin (I-19, sc-1616, Santa Cruz), PKR (K-17, sc-707, Santa Cruz), p-PKR (Thr451, sc-101784, Santa Cruz), p-eIF-2α (Ser-52, sc-12412-R Santa Cruz), or a monoclonal antibody directed against E1A (sc-430, Santa Cruz).
Data analysis
The density of the bands from digital images of PCR gels and Western blots were obtained using ImageJ. The obtained density values were used to calculate the relative density of each band using actin as the internal control. A minimum of three separate experiments were used to calculate the standard deviation between the repetitions. The statistical significance of the observed difference between HAdV2 and HAdV12 was determined with unpaired Student's t-test using the GraphPad Prism software version 5.01 (Graph-Pad Software, San Diego, CA).
Complementation of HAdV-12 translation by VA RNA cotransfection IMR90 cells seeded in 12-well chamber slides were transfected with 0.5 mg plasmid pHindB, expressing HAdV-2 VA RNAI and VARNAII (Svensson and Akusjarvi, 1984) or pAd12VA, expressing HAdV-12 VA RNA. At 24 h post-transfection cells were infected with HAdV-12 (10 FFU/cell). After an additional 48 h incubation hexon protein expression was visualized by indirect immunofluorescence using a pan-hexon antibody (Millipore, MAB8052). In brief, infected cells were washed three times with PBS, fixed in 95% methanol for 5 min at room temperature, washed 3 Â 5 min with PBS followed by a blocking step with 1% BSA for 30 min at room temperature. The primary pan-hexon antibody (diluted 1ː500) was incubated overnight at 4 1C. After a 3 Â 10 min wash with PBS the secondary antibody (anti-mouse IgG-FITC, F9006, Sigma, diluted 1:400) was added and incubated for 1 h at room temperature. Finally, the slides were washed 3 Â 10 min with PBS and mounted with coverslips. Images were acquired at 20 Â magnification using a Nikon Eclipse 90i microscope and the NIS-Elements Ar 3.6 software. The intensity of the hexon signal was determined using ImageJ and the mean fold increase from three experiments calculated was compared to mock transfected cells.
